Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes — Stella

Home/Breast Cancer/TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes

Trial locations(1 site)

Germany

Kliniken Essen-Mitte (KEM), Essen

Key details

Sponsor

Kliniken Essen-Mitte

Enrollment target

~150 participants

Started

March 2022

Primary completion

March 2027

Age range

18 Years and older

Last updated February 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.